MYCN and neuroblastoma: Considering we found downregulated the NK pathways in MNA-NB patients in the two cohorts used in this study (Figure 4A) and because we also found CD276 down-regulation after MYCN inhibition by BGA002 (Figure 4B), we evaluated the potential effect of MYCN inhibition by BGA002 of the reactivation capacity on NK lysis of MNA NB cells (we used Kelly-luc, MNA cell-line transfected with luciferase).